Bin Bin serves as Chief Executive Officer at multiple organizations including Huahai US, Inc., Prinston Pharmaceutical Inc., and Solco Healthcare US LLC since November 2021. Additionally, Bin Bin has held the role of Chief Executive Officer at Huahai Investment Co., Ltd. since July 2014 and previously led Zhejiang Huahai Pharmaceutical Co., Ltd. as Head of Chief Executive Office from January 2011 to July 2014.
This person is not in any teams
Prinston Pharmaceutical Inc.
We are a fully integrated pharmaceutical company located in Cranbury, engaged in developing and sales & marketing of generic pharmaceutical products in North American and South American markets. Since launching our first product, Benazepril in 2010, we have launched 11 products in U.S. market. Through reliable products’ quality, manufacturing capability and competitively strategic API resources from China, we have successfully reduced the medical cost for American buyers and help millions of patients against their illness.